| Anti Xa‐HC activity HEM vs RIVA (ng/mL) | Anti Xa‐HC activity INN vs RIVA (ng/mL) | Anti XA‐HC activity STA vs RIVA (ng/mL) |
Bland Altman Anti Xa‐HC U/mL HEM‐INN |
Bland Altman Anti Xa‐HC U/mL HEM‐STA |
Bland Altman Anti Xa‐HC U/mL INN‐STA |
|
|---|---|---|---|---|---|---|
| R 2 | 0.955 | 0.964 | 0.828 | ‐ | ‐ | ‐ |
| Linear regression Slope (95%CI) (RIVA samples) |
0.008 (0.007 to 0.009) |
0.0086 (0.008 to 0.009) |
0.010 (0.007 to 0.0129) |
‐ | ‐ | ‐ |
|
Linear regression Y intercept (95%CI) (RIVA Samples) |
‐0.112 (‐0.228 to 0.004) |
‐0.081 (‐0.193 to 0.031) |
0.348 (0.049 to 0.647) |
‐ | ‐ | ‐ |
|
Bland Altman BIAS (95% CI) Anti Xa‐HC U/mL RIVA samples |
‐ | ‐ | ‐ |
‐0.086 (‐0.126 to ‐0.046) |
‐0.630 (‐0.854 to ‐0.406) |
‐0.544 (‐0.765 to ‐0.322) |
|
Bland Altman BIAS (95% CI) Anti Xa‐HC U/mL LMWH samples |
‐ | ‐ | ‐ |
‐0.041 (‐0.097 to ‐0.014) |
‐0.012 (‐0.088 to 0.065) |
0.030 (‐0.028 to 0.088) |